News Focus
News Focus
Replies to #99120 on Biotech Values
icon url

DFRAI

07/21/10 11:20 AM

#99233 RE: MotionMan #99120

MNTA - motionman

MNTA lovenox success or failure hinges on a crosseye fda employee who for the last 4 years starred at documents and shuffled papers back and forth

The entire company future as far as lovenox, copaxone, fob follow on hinges on this decision - so pretty much is a house of cards at this time.

Management should not have allowed this to happen - M118 should have been partnered already and new funds raised if needed.

Its an explosive situation with 3-4 dollars bottom if negative and 40 top range.